Global Acute Vulvovaginal Candidiasis Treatment Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Acute Vulvovaginal Candidiasis Treatment Market Size 2017-2028

2.1.2 Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Acute Vulvovaginal Candidiasis Treatment Segment by Type

2.2.1 Clotrimazole

2.2.2 Nystatin

2.2.3 Fluconazole

2.2.4 Ketoconazole

2.2.5 Terbinafine

2.2.6 Terconazole

2.2.7 Others

2.3 Acute Vulvovaginal Candidiasis Treatment Market Size by Type

2.3.1 Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2017-2022)

2.4 Acute Vulvovaginal Candidiasis Treatment Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Acute Vulvovaginal Candidiasis Treatment Market Size by Application

2.5.1 Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2017-2022)

3 Acute Vulvovaginal Candidiasis Treatment Market Size by Player

3.1 Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Players

3.1.1 Global Acute Vulvovaginal Candidiasis Treatment Revenue by Players (2020-2022)

3.1.2 Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Acute Vulvovaginal Candidiasis Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Acute Vulvovaginal Candidiasis Treatment by Regions

4.1 Acute Vulvovaginal Candidiasis Treatment Market Size by Regions (2017-2022)

4.2 Americas Acute Vulvovaginal Candidiasis Treatment Market Size Growth (2017-2022)

4.3 APAC Acute Vulvovaginal Candidiasis Treatment Market Size Growth (2017-2022)

4.4 Europe Acute Vulvovaginal Candidiasis Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2017-2022)

5.2 Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2017-2022)

5.3 Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Region (2017-2022)

6.2 APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2017-2022)

6.3 APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Acute Vulvovaginal Candidiasis Treatment by Country (2017-2022)

7.2 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2017-2022)

7.3 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment by Region (2017-2022)

8.2 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.1 Global Acute Vulvovaginal Candidiasis Treatment Forecast by Regions (2023-2028)

10.1.1 Global Acute Vulvovaginal Candidiasis Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Acute Vulvovaginal Candidiasis Treatment Forecast

10.1.3 APAC Acute Vulvovaginal Candidiasis Treatment Forecast

10.1.4 Europe Acute Vulvovaginal Candidiasis Treatment Forecast

10.1.5 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Forecast

10.2 Americas Acute Vulvovaginal Candidiasis Treatment Forecast by Country (2023-2028)

10.2.1 United States Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.2.2 Canada Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.2.3 Mexico Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.2.4 Brazil Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.3 APAC Acute Vulvovaginal Candidiasis Treatment Forecast by Region (2023-2028)

10.3.1 China Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.3.2 Japan Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.3.3 Korea Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.3.4 Southeast Asia Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.3.5 India Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.3.6 Australia Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.4 Europe Acute Vulvovaginal Candidiasis Treatment Forecast by Country (2023-2028)

10.4.1 Germany Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.4.2 France Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.4.3 UK Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.4.4 Italy Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.4.5 Russia Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.5 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.5.2 South Africa Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.5.3 Israel Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.5.4 Turkey Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.5.5 GCC Countries Acute Vulvovaginal Candidiasis Treatment Market Forecast

10.6 Global Acute Vulvovaginal Candidiasis Treatment Forecast by Type (2023-2028)

10.7 Global Acute Vulvovaginal Candidiasis Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Mycovia Pharmaceuticals, Inc

11.1.1 Mycovia Pharmaceuticals, Inc Company Information

11.1.2 Mycovia Pharmaceuticals, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered

11.1.3 Mycovia Pharmaceuticals, Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Mycovia Pharmaceuticals, Inc Main Business Overview

11.1.5 Mycovia Pharmaceuticals, Inc Latest Developments

11.2 Scynexis, Inc

11.2.1 Scynexis, Inc Company Information

11.2.2 Scynexis, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered

11.2.3 Scynexis, Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Scynexis, Inc Main Business Overview

11.2.5 Scynexis, Inc Latest Developments

11.3 Basilea Pharmaceutica Ltd

11.3.1 Basilea Pharmaceutica Ltd Company Information

11.3.2 Basilea Pharmaceutica Ltd Acute Vulvovaginal Candidiasis Treatment Product Offered

11.3.3 Basilea Pharmaceutica Ltd Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Basilea Pharmaceutica Ltd Main Business Overview

11.3.5 Basilea Pharmaceutica Ltd Latest Developments

11.4 Astellas Pharma Inc

11.4.1 Astellas Pharma Inc Company Information

11.4.2 Astellas Pharma Inc Acute Vulvovaginal Candidiasis Treatment Product Offered

11.4.3 Astellas Pharma Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Astellas Pharma Inc Main Business Overview

11.4.5 Astellas Pharma Inc Latest Developments

11.5 Grupo Ferrer Internacional, S.A

11.5.1 Grupo Ferrer Internacional, S.A Company Information

11.5.2 Grupo Ferrer Internacional, S.A Acute Vulvovaginal Candidiasis Treatment Product Offered

11.5.3 Grupo Ferrer Internacional, S.A Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Grupo Ferrer Internacional, S.A Main Business Overview

11.5.5 Grupo Ferrer Internacional, S.A Latest Developments

11.6 Pacgen Life Science Corporation

11.6.1 Pacgen Life Science Corporation Company Information

11.6.2 Pacgen Life Science Corporation Acute Vulvovaginal Candidiasis Treatment Product Offered

11.6.3 Pacgen Life Science Corporation Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Pacgen Life Science Corporation Main Business Overview

11.6.5 Pacgen Life Science Corporation Latest Developments

11.7 NovaDigm Therapeutics, Inc

11.7.1 NovaDigm Therapeutics, Inc Company Information

11.7.2 NovaDigm Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered

11.7.3 NovaDigm Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 NovaDigm Therapeutics, Inc Main Business Overview

11.7.5 NovaDigm Therapeutics, Inc Latest Developments

11.8 Cidara Therapeutics, Inc

11.8.1 Cidara Therapeutics, Inc Company Information

11.8.2 Cidara Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered

11.8.3 Cidara Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Cidara Therapeutics, Inc Main Business Overview

11.8.5 Cidara Therapeutics, Inc Latest Developments

11.9 Amplyx Pharmaceuticals Inc

11.9.1 Amplyx Pharmaceuticals Inc Company Information

11.9.2 Amplyx Pharmaceuticals Inc Acute Vulvovaginal Candidiasis Treatment Product Offered

11.9.3 Amplyx Pharmaceuticals Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Amplyx Pharmaceuticals Inc Main Business Overview

11.9.5 Amplyx Pharmaceuticals Inc Latest Developments

11.10 Pfizer, Inc.

11.10.1 Pfizer, Inc. Company Information

11.10.2 Pfizer, Inc. Acute Vulvovaginal Candidiasis Treatment Product Offered

11.10.3 Pfizer, Inc. Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Pfizer, Inc. Main Business Overview

11.10.5 Pfizer, Inc. Latest Developments

12 Research Findings and Conclusion

Table 1. Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Clotrimazole

Table 3. Major Players of Nystatin

Table 4. Major Players of Fluconazole

Table 5. Major Players of Ketoconazole

Table 6. Major Players of Terbinafine

Table 7. Major Players of Terconazole

Table 8. Major Players of Others

Table 9. Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 11. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2017-2022)

Table 12. Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 13. Global Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 14. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2017-2022)

Table 15. Global Acute Vulvovaginal Candidiasis Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 16. Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Player (2020-2022)

Table 17. Acute Vulvovaginal Candidiasis Treatment Key Players Head office and Products Offered

Table 18. Acute Vulvovaginal Candidiasis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 19. New Products and Potential Entrants

Table 20. Mergers & Acquisitions, Expansion

Table 21. Global Acute Vulvovaginal Candidiasis Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 22. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Regions (2017-2022)

Table 23. Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 24. Americas Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Country (2017-2022)

Table 25. Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 26. Americas Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2017-2022)

Table 27. Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 28. Americas Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2017-2022)

Table 29. APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 30. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Region (2017-2022)

Table 31. APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 32. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2017-2022)

Table 33. APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 34. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2017-2022)

Table 35. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 36. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Country (2017-2022)

Table 37. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 38. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2017-2022)

Table 39. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 40. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2017-2022)

Table 41. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Region (2017-2022)

Table 43. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2017-2022)

Table 45. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 46. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2017-2022)

Table 47. Key Market Drivers & Growth Opportunities of Acute Vulvovaginal Candidiasis Treatment

Table 48. Key Market Challenges & Risks of Acute Vulvovaginal Candidiasis Treatment

Table 49. Key Industry Trends of Acute Vulvovaginal Candidiasis Treatment

Table 50. Global Acute Vulvovaginal Candidiasis Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 51. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 52. Global Acute Vulvovaginal Candidiasis Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 53. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 54. Global Acute Vulvovaginal Candidiasis Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 55. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 56. Mycovia Pharmaceuticals, Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors

Table 57. Mycovia Pharmaceuticals, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered

Table 58. Mycovia Pharmaceuticals, Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 59. Mycovia Pharmaceuticals, Inc Main Business

Table 60. Mycovia Pharmaceuticals, Inc Latest Developments

Table 61. Scynexis, Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors

Table 62. Scynexis, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered

Table 63. Scynexis, Inc Main Business

Table 64. Scynexis, Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Scynexis, Inc Latest Developments

Table 66. Basilea Pharmaceutica Ltd Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors

Table 67. Basilea Pharmaceutica Ltd Acute Vulvovaginal Candidiasis Treatment Product Offered

Table 68. Basilea Pharmaceutica Ltd Main Business

Table 69. Basilea Pharmaceutica Ltd Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Basilea Pharmaceutica Ltd Latest Developments

Table 71. Astellas Pharma Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors

Table 72. Astellas Pharma Inc Acute Vulvovaginal Candidiasis Treatment Product Offered

Table 73. Astellas Pharma Inc Main Business

Table 74. Astellas Pharma Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Astellas Pharma Inc Latest Developments

Table 76. Grupo Ferrer Internacional, S.A Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors

Table 77. Grupo Ferrer Internacional, S.A Acute Vulvovaginal Candidiasis Treatment Product Offered

Table 78. Grupo Ferrer Internacional, S.A Main Business

Table 79. Grupo Ferrer Internacional, S.A Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Grupo Ferrer Internacional, S.A Latest Developments

Table 81. Pacgen Life Science Corporation Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors

Table 82. Pacgen Life Science Corporation Acute Vulvovaginal Candidiasis Treatment Product Offered

Table 83. Pacgen Life Science Corporation Main Business

Table 84. Pacgen Life Science Corporation Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Pacgen Life Science Corporation Latest Developments

Table 86. NovaDigm Therapeutics, Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors

Table 87. NovaDigm Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered

Table 88. NovaDigm Therapeutics, Inc Main Business

Table 89. NovaDigm Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. NovaDigm Therapeutics, Inc Latest Developments

Table 91. Cidara Therapeutics, Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors

Table 92. Cidara Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered

Table 93. Cidara Therapeutics, Inc Main Business

Table 94. Cidara Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Cidara Therapeutics, Inc Latest Developments

Table 96. Amplyx Pharmaceuticals Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors

Table 97. Amplyx Pharmaceuticals Inc Acute Vulvovaginal Candidiasis Treatment Product Offered

Table 98. Amplyx Pharmaceuticals Inc Main Business

Table 99. Amplyx Pharmaceuticals Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Amplyx Pharmaceuticals Inc Latest Developments

Table 101. Pfizer, Inc. Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors

Table 102. Pfizer, Inc. Acute Vulvovaginal Candidiasis Treatment Product Offered

Table 103. Pfizer, Inc. Main Business

Table 104. Pfizer, Inc. Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Pfizer, Inc. Latest Developments

List of Figures

Figure 1. Acute Vulvovaginal Candidiasis Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Acute Vulvovaginal Candidiasis Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type in 2021

Figure 7. Acute Vulvovaginal Candidiasis Treatment in Hospital Pharmacies

Figure 8. Global Acute Vulvovaginal Candidiasis Treatment Market: Hospital Pharmacies (2017-2022) & ($ Millions)

Figure 9. Acute Vulvovaginal Candidiasis Treatment in Retail Pharmacies

Figure 10. Global Acute Vulvovaginal Candidiasis Treatment Market: Retail Pharmacies (2017-2022) & ($ Millions)

Figure 11. Acute Vulvovaginal Candidiasis Treatment in Online Pharmacies

Figure 12. Global Acute Vulvovaginal Candidiasis Treatment Market: Online Pharmacies (2017-2022) & ($ Millions)

Figure 13. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application in 2021

Figure 14. Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Player in 2021

Figure 15. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Acute Vulvovaginal Candidiasis Treatment Market Size 2017-2022 ($ Millions)

Figure 17. APAC Acute Vulvovaginal Candidiasis Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Europe Acute Vulvovaginal Candidiasis Treatment Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Americas Acute Vulvovaginal Candidiasis Treatment Value Market Share by Country in 2021

Figure 21. Americas Acute Vulvovaginal Candidiasis Treatment Consumption Market Share by Type in 2021

Figure 22. Americas Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application in 2021

Figure 23. United States Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Region in 2021

Figure 28. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application in 2021

Figure 29. China Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Country in 2021

Figure 36. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type in 2021

Figure 37. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application in 2021

Figure 38. Germany Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application in 2021

Figure 46. Egypt Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 52. APAC Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 53. Europe Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 55. United States Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Canada Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 59. China Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Japan Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 61. Korea Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 63. India Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Australia Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 65. Germany Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 66. France Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 67. UK Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Italy Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Russia Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Spain Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Israel Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Acute Vulvovaginal Candidiasis Treatment Market Size 2023-2028 ($ Millions)